Product Code: GVR-3-68038-758-2
PTA Balloon Catheter Market Growth & Trends:
The global PTA balloon catheter market size is expected to reach USD 4.62 billion by 2030, expanding at a CAGR of 8.32% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing incidence of peripheral artery disorder and the rising number of Percutaneous Coronary Intervention (PCI) procedures in developing countries are key factors driving the market.
The adoption of a sedentary lifestyle by most of the population has increased the prevalence rate of various types of cardiovascular diseases worldwide. An increase in the number of cases of cardiovascular diseases across the globe is expected to boost the adoption of various procedures-such as cardiac catheterizations, angioplasty, and Percutaneous Coronary Intervention (PCI)-to treat such conditions, wherein PTA balloon catheters are among the essential requirements.
The COVID-19 pandemic resulted in a decline in the number of patient encounters, leading to a reduction in the demand for surgical procedures, thereby impacting the industry growth. According to Elsevier, the number of coronary angioplasty surgeries was 11.2% in 2020, which is lower than the previously reported data. According to the National Library of Medicine, the U.S. witnessed a 52.7% decline in adult cardiac surgeries in 2020. In the later phase, as the restrictions were lifted in several countries, the volume of cardiac and peripheral surgical procedures increased. This is expected to increase the demand for angioplasty surgical devices such as PTA balloon catheters.
PTA Balloon Catheter Market Report Highlights:
- North America dominated the market in 2023. This can be attributed to the higher product availability, high demand for surgical procedures, and better awareness in the region
- Asia Pacific is expected to exhibit the fastest growth rate during the forecast period due to government initiatives and increasing incidence of target disorders
- Supportive government regulations to commercialize medical devices in Latin America are expected to impel industry growth. For instance, most Latin American countries only require the U.S. FDA or CE mark approval for filing marketing approvals
- Incorporation of the latest health technologies, partnerships and collaborations, product expansion, and mergers & acquisitions are some of the strategies being adopted by key players to gain a competitive edge in the market. For instance, in February 2022, Boston Scientific Corporation acquired Baylis Medical Company, Inc., a medical device company primarily providing solutions to support catheter-based left heart procedures
- The shortage of cardiac surgeons worldwide is a big concern. Low-income countries are facing this issue more severely. For instance, North Africa has only one surgeon per 1.1 million people. This is resulting in restricting the number of surgeries that could be performed, hindering industry growth
Table of Contents
Chapter 1. PTA Balloon Catheter Market: Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.1.1. Segment Definitions
- 1.1.1.1. Material Types Segment
- 1.1.1.2. Application Segment
- 1.1.1.3. End use Segment
- 1.2. Regional Scope
- 1.3. Estimates and Forecast Timeline
- 1.4. Objectives
- 1.4.1. Objective - 1
- 1.4.2. Objective - 2
- 1.5. Research Methodology
- 1.6. Information Procurement
- 1.6.1. Purchased Database
- 1.6.2. GVR's Internal Database
- 1.6.3. Secondary Sources
- 1.6.4. Primary Research
- 1.7. Information Or Data Analysis
- 1.7.1. Data Analysis Models
- 1.8. Market Formulation & Validation
- 1.9. Model Details
- 1.9.1. Commodity Flow Analysis
- 1.10. List of Primary Sources
- 1.11. List of Abbreviations
Chapter 2. PTA Balloon Catheter Market: Executive Summary
- 2.1. Market Snapshot
- 2.2. Material Types Snapshots
- 2.3. Application and End Use Snapshot
- 2.4. Competitive Landscape Snapshot
Chapter 3. PTA Balloon Catheter Market: Variables, Trends, & Scope
- 3.1. Market Segmentation and Scope
- 3.2. Market Lineage Outlook
- 3.2.1. Parent Market Outlook
- 3.2.2. Related/Ancillary Market Outlook
- 3.3. Market Dynamics
- 3.4. Market Drivers Analysis
- 3.4.1. Increasing Prevalence of Cardiovascular Diseases
- 3.4.2. Growing Adoption of Minimally Invasive Procedures
- 3.5. Market Restraint Analysis
- 3.5.1. Potential Complications Associated with Angioplasty Procedures
- 3.5.2. Stringent Regulatory Policies
- 3.6. PTA Balloon Catheter Market Analysis Tools
- 3.6.1. Industry Analysis - Porter's
- 3.6.1.1. Supplier Power
- 3.6.1.2. Buyer Power
- 3.6.1.3. Substitution Threat
- 3.6.1.4. Threat of New Entrant
- 3.6.1.5. Competitive Rivalry
- 3.6.2. PESTLE Analysis
- 3.6.2.1. Political Landscape
- 3.6.2.2. Technological Landscape
- 3.6.2.3. Economic Landscape
- 3.6.3. Pricing Analysis
Chapter 4. PTA Balloon Catheter: Material Type Estimates & Trend Analysis
- 4.1. Type Market Share, 2023 & 2030
- 4.2. Segment Dashboard
- 4.3. Global PTA Balloon Catheter Market by Material Type Outlook
- 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
- 4.4.1. Polyurethane
- 4.4.1.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 4.4.2. Nylon
- 4.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 4.4.3. Others
- 4.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 5. PTA Balloon Catheter: Application Estimates & Trend Analysis
- 5.1. Application Market Share, 2023 & 2030
- 5.2. Segment Dashboard
- 5.3. Global PTA Balloon Catheter Market by Application Outlook
- 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
- 5.4.1. Peripheral Artery Disease
- 5.4.1.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 5.4.2. Coronary Artery Disease
- 5.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 6. PTA Balloon Catheter: End use Estimates & Trend Analysis
- 6.1. End use Market Share, 2023 & 2030
- 6.2. Segment Dashboard
- 6.3. Global PTA Balloon Catheter Market by End use Outlook
- 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
- 6.4.1. Hospitals
- 6.4.1.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 6.4.2. Ambulatory Surgical Centers
- 6.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 6.4.3. Others
- 6.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 7. Regional Business Analysis
- 7.1. Regional Market Share Analysis, 2023 & 2030
- 7.2. Regional Market Dashboard
- 7.3. Global Regional Market Snapshot
- 7.4. Marker Size, & Forecasts Trend Analysis, 2018 to 2030:
- 7.5. North America
- 7.5.1. U.S.
- 7.5.1.1. Key Country Dynamics
- 7.5.1.2. Competitive Scenario
- 7.5.1.3. Regulatory Framework
- 7.5.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.5.2. Canada
- 7.5.2.1. Key Country Dynamics
- 7.5.2.2. Competitive Scenario
- 7.5.2.3. Regulatory Framework
- 7.5.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.6. Europe
- 7.6.1. UK
- 7.6.1.1. Key Country Dynamics
- 7.6.1.2. Competitive Scenario
- 7.6.1.3. Regulatory Framework
- 7.6.1.4. UK Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.6.2. Germany
- 7.6.2.1. Key Country Dynamics
- 7.6.2.2. Competitive Scenario
- 7.6.2.3. Regulatory Framework
- 7.6.2.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.6.3. Spain
- 7.6.3.1. Key Country Dynamics
- 7.6.3.2. Competitive Scenario
- 7.6.3.3. Regulatory Framework
- 7.6.3.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.6.4. France
- 7.6.4.1. Key Country Dynamics
- 7.6.4.2. Competitive Scenario
- 7.6.4.3. Regulatory Framework
- 7.6.4.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.6.5. Italy
- 7.6.5.1. Key Country Dynamics
- 7.6.5.2. Competitive Scenario
- 7.6.5.3. Regulatory Framework
- 7.6.5.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.6.6. Denmark
- 7.6.6.1. Key Country Dynamics
- 7.6.6.2. Competitive Scenario
- 7.6.6.3. Regulatory Framework
- 7.6.6.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.6.6.5.
- 7.6.7. Sweden
- 7.6.7.1. Key Country Dynamics
- 7.6.7.2. Competitive Scenario
- 7.6.7.3. Regulatory Framework
- 7.6.7.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.6.8. Norway
- 7.6.8.1. Key Country Dynamics
- 7.6.8.2. Competitive Scenario
- 7.6.8.3. Regulatory Framework
- 7.6.8.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.7. Asia Pacific
- 7.7.1. JAPAN
- 7.7.1.1. Key Country Dynamics
- 7.7.1.2. Competitive Scenario
- 7.7.1.3. Regulatory Framework
- 7.7.1.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.7.2. China
- 7.7.2.1. Key Country Dynamics
- 7.7.2.2. Competitive Scenario
- 7.7.2.3. Regulatory Framework
- 7.7.2.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.7.3. India
- 7.7.3.1. Key Country Dynamics
- 7.7.3.2. Competitive Scenario
- 7.7.3.3. Regulatory Framework
- 7.7.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.7.4. South Korea
- 7.7.4.1. Key Country Dynamics
- 7.7.4.2. Competitive Scenario
- 7.7.4.3. Regulatory Framework
- 7.7.4.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.7.5. Thailand
- 7.7.5.1. Key Country Dynamics
- 7.7.5.2. Competitive Scenario
- 7.7.5.3. Regulatory Framework
- 7.7.5.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.7.6. Australia
- 7.7.6.1. Key Country Dynamics
- 7.7.6.2. Competitive Scenario
- 7.7.6.3. Regulatory Framework
- 7.7.6.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.8. Latin America
- 7.8.1. Brazil
- 7.8.1.1. Key Country Dynamics
- 7.8.1.2. Competitive Scenario
- 7.8.1.3. Regulatory Framework
- 7.8.1.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.8.2. Mexico
- 7.8.2.1. Key Country Dynamics
- 7.8.2.2. Competitive Scenario
- 7.8.2.3. Regulatory Framework
- 7.8.2.4. Mexico PTA Balloon Catheter Market, 2018 - 2030 (USD Million)
- 7.8.3. Argentina
- 7.8.3.1. Key Country Dynamics
- 7.8.3.2. Competitive Scenario
- 7.8.3.3. Regulatory Framework
- 7.8.3.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.9. MEA
- 7.9.1. MEA PTA Balloon Catheter Market, 2018 - 2030 (USD Million)
- 7.9.2. South Africa
- 7.9.2.1. Key Country Dynamics
- 7.9.2.2. Competitive Scenario
- 7.9.2.3. Regulatory Framework
- 7.9.2.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.9.3. Saudi Arabia
- 7.9.3.1. Key Country Dynamics
- 7.9.3.2. Competitive Scenario
- 7.9.3.3. Regulatory Framework
- 7.9.3.4. Saudi Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.9.4. UAE
- 7.9.4.1. Key Country Dynamics
- 7.9.4.2. Competitive Scenario
- 7.9.4.3. Regulatory Framework
- 7.9.4.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.9.5. Kuwait
- 7.9.5.1. Key Country Dynamics
- 7.9.5.2. Competitive Scenario
- 7.9.5.3. Regulatory Framework
- 7.9.5.4. Kuwait Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, by Key Market Participants
- 8.2. Company /Competition Categorization
- 8.3. Vendor Landscape
- 8.3.1. List of Key Distributors and Channel Partners
- 8.3.2. Key Customers
- 8.3.3. Key Company Market Share Analysis, 2023
- 8.3.4. Boston Scientific Corporation
- 8.3.4.1. Overview
- 8.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.3.4.3. Product Benchmarking
- 8.3.4.4. Strategic Initiatives
- 8.3.5. Cardinal Health
- 8.3.5.1. Overview
- 8.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.3.5.3. Product Benchmarking
- 8.3.5.4. Strategic Initiatives
- 8.3.6. Medtronic Plc
- 8.3.6.1. Overview
- 8.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.3.6.3. Product Benchmarking
- 8.3.6.4. Strategic Initiatives
- 8.3.7. Natec Medical
- 8.3.7.1. Overview
- 8.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.3.7.3. Product Benchmarking
- 8.3.7.4. Strategic Initiatives
- 8.3.8. Terumo Corporation
- 8.3.8.1. Overview
- 8.3.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.3.8.3. Product Benchmarking
- 8.3.8.4. Strategic Initiatives
- 8.3.9. Cook Medical
- 8.3.9.1. Overview
- 8.3.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.3.9.3. Product Benchmarking
- 8.3.9.4. Strategic Initiatives
- 8.3.10. Biotronik
- 8.3.10.1. Overview
- 8.3.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.3.10.3. Product Benchmarking
- 8.3.10.4. Strategic Initiatives
- 8.3.11. Surmodics, Inc.
- 8.3.11.1. Overview
- 8.3.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.3.11.3. Product Benchmarking
- 8.3.11.4. Strategic Initiatives
- 8.3.12. Andratec
- 8.3.12.1. Overview
- 8.3.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.3.12.3. Product Benchmarking
- 8.3.12.4. Strategic Initiatives